rs74820788
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002150.3(HPD):c.499G>A(p.Asp167Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,612,916 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002150.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPD | NM_002150.3 | c.499G>A | p.Asp167Asn | missense_variant | 8/14 | ENST00000289004.8 | NP_002141.2 | |
HPD | NM_001171993.2 | c.382G>A | p.Asp128Asn | missense_variant | 10/16 | NP_001165464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPD | ENST00000289004.8 | c.499G>A | p.Asp167Asn | missense_variant | 8/14 | 1 | NM_002150.3 | ENSP00000289004.4 | ||
HPD | ENST00000543163.5 | c.382G>A | p.Asp128Asn | missense_variant | 9/15 | 5 | ENSP00000441677.1 | |||
HPD | ENST00000542159.2 | n.683G>A | non_coding_transcript_exon_variant | 5/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00183 AC: 278AN: 152142Hom.: 4 Cov.: 31
GnomAD3 exomes AF: 0.000501 AC: 126AN: 251426Hom.: 1 AF XY: 0.000353 AC XY: 48AN XY: 135900
GnomAD4 exome AF: 0.000175 AC: 255AN: 1460656Hom.: 0 Cov.: 30 AF XY: 0.000158 AC XY: 115AN XY: 726750
GnomAD4 genome AF: 0.00183 AC: 278AN: 152260Hom.: 4 Cov.: 31 AF XY: 0.00160 AC XY: 119AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | HPD: BP4, BS2 - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Tyrosinemia type III;C2931042:Hawkinsinuria Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at